Activin and Inhibin

3-O-Methyltolcapone-d 7 is a deuterium labeled 3-O-Methyltolcapone. 3-O-Methyltolcapone is a metabolite of Tolcapone. Tolcapone is an orally active, reversible, selective and potent COMT inhibitor . Tolcapone crosses the blood-brain barrier, and can

3-O-Methyltolcapone-d 7 is a deuterium labeled 3-O-Methyltolcapone. 3-O-Methyltolcapone is a metabolite of Tolcapone. Tolcapone is an orally active, reversible, selective and potent COMT inhibitor . Tolcapone crosses the blood-brain barrier, and can

Maximum Absorption Wavelength:280(DMA)nm.

Maximum Absorption Wavelength:280(DMA)nm.

3α-Aminocholestane is a selective SH2 domain-containing inositol-5′-phosphatase 1 ( SHIP1 ) inhibitor with an IC 50 of ~2.5 μM.In VitroOPM2 cell viability is effectively reduced by 3α-Aminocholestane (3AC) treatment. RPMI8226 and U266 cells show

3α-Aminocholestane is a selective SH2 domain-containing inositol-5′-phosphatase 1 ( SHIP1 ) inhibitor with an IC 50 of ~2.5 μM.In VitroOPM2 cell viability is effectively reduced by 3α-Aminocholestane (3AC) treatment. RPMI8226 and U266 cells show

3α-Aminocholestane is a selective SH2 domain-containing inositol-5′-phosphatase 1 ( SHIP1 ) inhibitor with an IC 50 of ~2.5 μM.In VitroOPM2 cell viability is effectively reduced by 3α-Aminocholestane (3AC) treatment. RPMI8226 and U266 cells show

3α-Aminocholestane is a selective SH2 domain-containing inositol-5′-phosphatase 1 ( SHIP1 ) inhibitor with an IC 50 of ~2.5 μM.In VitroOPM2 cell viability is effectively reduced by 3α-Aminocholestane (3AC) treatment. RPMI8226 and U266 cells show

3α-Aminocholestane is a selective SH2 domain-containing inositol-5′-phosphatase 1 ( SHIP1 ) inhibitor with an IC 50 of ~2.5 μM.In VitroOPM2 cell viability is effectively reduced by 3α-Aminocholestane (3AC) treatment. RPMI8226 and U266 cells show

3α-Aminocholestane is a selective SH2 domain-containing inositol-5′-phosphatase 1 ( SHIP1 ) inhibitor with an IC 50 of ~2.5 μM.In VitroOPM2 cell viability is effectively reduced by 3α-Aminocholestane (3AC) treatment. RPMI8226 and U266 cells show

4'-Methylchrysoeriol is a potent inhibitor of Cytochrome P450 enzymes, with an IC 50 of 19 nM for human P450 1B1-dependent EROD.In Vitro4'-Methylchrysoeriol (34DM57DHF) is a potent inhibitor of P450 enzymes, particularly for P450 1B1, with an IC 50

4'-Methylchrysoeriol is a potent inhibitor of Cytochrome P450 enzymes, with an IC 50 of 19 nM for human P450 1B1-dependent EROD.In Vitro4'-Methylchrysoeriol (34DM57DHF) is a potent inhibitor of P450 enzymes, particularly for P450 1B1, with an IC 50